David J. Rabbolini

ORCID: 0000-0003-1991-9650
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Platelet Disorders and Treatments
  • Blood groups and transfusion
  • Venous Thromboembolism Diagnosis and Management
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Blood properties and coagulation
  • Blood disorders and treatments
  • Cell Adhesion Molecules Research
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Trauma, Hemostasis, Coagulopathy, Resuscitation
  • Immunodeficiency and Autoimmune Disorders
  • Chronic Lymphocytic Leukemia Research
  • Heparin-Induced Thrombocytopenia and Thrombosis
  • Acute Myocardial Infarction Research
  • Muscle and Compartmental Disorders
  • Autoimmune Bullous Skin Diseases
  • Liver Disease Diagnosis and Treatment
  • COVID-19 Clinical Research Studies
  • Intramuscular injections and effects
  • Inflammatory Biomarkers in Disease Prognosis
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Ubiquitin and proteasome pathways
  • Chronic Myeloid Leukemia Treatments
  • Blood Coagulation and Thrombosis Mechanisms
  • Adenosine and Purinergic Signaling
  • Central Venous Catheters and Hemodialysis

The University of Sydney
2014-2024

Oxford University Hospitals NHS Trust
2023-2024

St Vincent's Hospital Sydney
2018-2023

UNSW Sydney
2023

St Vincent's Health
2023

Royal North Shore Hospital
2014-2022

Lismore Base Hospital
2019-2022

Northern Sydney Local Health District
2019-2022

Faculty of 1000 (United States)
2019

ACT Government
2013-2016

Consistent with the biochemistry of coronaviruses as well established over decades, SARS-CoV-2 makes its initial attachment to host cells through binding spike protein (SP) sialylated glycans (containing monosaccharide sialic acid) on cell surface. The virus can then slide and enter via ACE2. SP attaches particularly tightly trillions red blood (RBCs), platelets endothelial in human body, each very densely coated acid surface molecules but having no ACE2 or minimal These interlaced...

10.31219/osf.io/hxucv preprint EN 2024-04-20

Fibrinolysisis is essential for vascular blood flow maintenance and triggered by endothelial platelet release of tissue plasminogen activator (t-PA). In certain critical conditions, e.g. sepsis, acute respiratory failure (ARF) trauma, the fibrinolytic response reduced may lead to widespread thrombosis multi-organ failure. The mechanisms underpinning fibrinolysis resistance include t-PA expression and/or release, plasmin effect due elevated inhibitor levels, increased consumption clearance....

10.1186/s13054-023-04329-5 article EN cc-by Critical Care 2023-02-10

Introduction Heparin-induced thrombocytopenia (HIT) is a prothrombotic disorder that occurs following the administration of heparin and caused by antibodies to platelet factor 4 heparin. Diagnosis HIT essential guide treatment strategies using non-heparin anticoagulants avoid unwanted potential fatal thromboembolic complications. This consensus statement, formulated members Thrombosis Haemostasis Society Australia New Zealand, provides an update on pathogenesis guidance diagnosis management...

10.5694/mja2.50213 article EN The Medical Journal of Australia 2019-06-01

Abstract Introduction Mean platelet volume ( MPV ) assists the differential diagnosis of inherited thrombocytopenia IT but lacks standardisation and varies between automated analysers. Classification based on mean diameter MPD has been proposed by an international collaborative study not validated. Methods To assess applicability to classify forms , digital images blood films from patients with established genetic causes for were generated, measured ZEISS Axio‐scanner Image J software) a...

10.1111/ijlh.12763 article EN International Journal of Laboratory Hematology 2017-11-16

MYH9-related disorders (MYH9-RDs) caused by mutation of the MYH9 gene which encodes non-muscle myosin heavy-chain-IIA (NMMHC-IIA), an important motor protein in hemopoietic cells, are most commonly encountered cause inherited macrothrombocytopenia. Despite distinguishing features including autosomal dominant mode inheritance, giant platelets on peripheral blood film accompanied leucocytes with cytoplasmic inclusion bodies (döhle-like bodies), these remain generally under-recognized and often...

10.1080/09537104.2017.1356920 article EN Platelets 2017-11-01

Essentials•Platelet function defects may cause atypical bleeding symptoms in immune thrombocytopenia (ITP).•An isolated platelet defect of collagen‐induced aggregation was explored a patient with ITP.•ITP mediated by antibodies to glycoprotein (GP) VI curtail receptor function.•Inclusion GPVI diagnostic antibody detection assays improve their utility.ACKNOWLEDGEMENTSThe authors acknowledge excellent laboratory assistance from Ms. Christine Lee and Anila Jahangiri.Idiopathic (ITP) is an...

10.1002/rth2.12033 article EN cc-by-nc-nd Research and Practice in Thrombosis and Haemostasis 2017-08-25

Consistent with the biochemistry of coronaviruses as well established over decades, SARS-CoV-2 makes its initial attachment to host cells through binding spike protein (SP) sialylated glycans (containing monosaccharide sialic acid) on cell surface. The virus can then slide and enter via ACE2. SP attaches particularly tightly trillions red blood (RBCs), platelets endothelial in human body, each very densely coated acid surface molecules but having no ACE2 or minimal These interlaced...

10.3390/v16040647 article EN cc-by Viruses 2024-04-22

Abstract Idiopathic systemic capillary leak syndrome ( SCLS ) is extremely rare but carries a high morbidity and mortality. The diagnosis made clinically by classic triad of hypotension, hypoalbuminaemia haemoconcentration. There have been recent advances in understanding the pathophysiological basis for effective prophylaxis. We report case to increase awareness condition highlight benefits prophylactic intravenous immunoglobulin this condition.

10.1111/imj.12271 article EN Internal Medicine Journal 2013-10-01

Growth factor-independent 1B (GFI1B) on the long arm of chromosome 9 encodes GFI1B transcription factor, a member GFI zinc (Zn)-finger transcriptional repressor family which plays pivo...

10.1080/09537104.2017.1317734 article EN Platelets 2017-06-05

Nilotinib is a second generation tyrosine kinase inhibitor, used in the treatment of chronic myelogenous leukaemia (CML).We assessed 72-year-old woman who was treated with nilotinib for CML.During year following commencement nilotinib, patient developed eight squamous cell carcinomas (SCCs) on her legs.Development SCC previously unreported adverse reaction to nilotinib.

10.1111/ced.12388 article EN Clinical and Experimental Dermatology 2014-08-22

Variants of the Diaphanous-Related Formin 1 (DIAPH-1) gene have recently been reported causing inherited macrothrombocytopenia. The essential/"diagnostic" characteristics associated with disorder are emerging; however, robust and complete criteria not established. Here, we report first cases DIAPH1-related in Australia caused by autosomal dominant gain-of-function DIAPH1 R1213X variant formed truncation protein within diaphanous auto-regulatory domain (DAD) loss regulatory motifs responsible...

10.1080/09537104.2021.1937593 article EN Platelets 2021-07-05

The use of mean platelet diameter (MPD) to classify inherited thrombocytopenia (IT) has been demonstrated in several studies. Alternatively, the volume (MPV) may be used, but macrothrombocytopenia this not available. We hypothesized that forward scatter (FSC) measurements using flow cytometry used for size-based classification IT. study aimed assess ability FSC measure size and whether it could as an alternative MPD or MPV.Blood samples were obtained from individuals undergoing investigation...

10.1080/09537104.2022.2052035 article EN Platelets 2022-03-22

Germline mutations of runt-related transcription factor-1 (RUNX1) cause familial platelet disorder with predisposition to myeloid malignancy (FPDMM), most commonly associated thrombocytopenia and propensity develop neoplasms. A key clinical question is which patients a family history should undergo genetic testing for

10.1002/rth2.12282 article EN cc-by-nc-nd Research and Practice in Thrombosis and Haemostasis 2019-12-13

Abstract Background Surgery on cardiopulmonary bypass (CPB) elicits a pleiomorphic systemic host response which, when severe, requires prolonged intensive care support. Given the substantial cross‐talk between inflammation, coagulation, and fibrinolysis, aim of this hypothesis‐generating observational study was to document kinetics fibrinolysis recovery post‐CPB using ClotPro® point‐of‐care viscoelastometry. Tissue plasminogen activator‐induced clot lysis time (TPA LT, s) correlated with...

10.1111/aas.14409 article EN Acta Anaesthesiologica Scandinavica 2024-03-18
Coming Soon ...